EMEA-002950-PIP01-20
Key facts
| Invented name |
Lutathera
|
| Active substance |
lutetium (177Lu) oxodotreotide
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0503/2021
|
| PIP number |
EMEA-002950-PIP01-20
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Treatment of gastroenteropancreatic neuroendocrine tumours
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Advanced Accelerator Applications
Email: infomed@adacap.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|